▲ SURGE

Zentalis Pharmaceuticals, Inc.

+60.1%
ZNTLNASDAQHealthcare2026-04-09
4.42
收盘价
2.76
前收盘价
+60.14%
涨幅
19.0x
量比

暴涨原因

2026년 3월 27일 H.C. Wainwright는 Zentalis Pharmaceuticals(ZNTL)에 대한 주식 등급을 재확인하고 목표 주가를 10달러로 유지했습니다.

  • ·2026년 3월 27일 H.C. Wainwright는 Zentalis Pharmaceuticals(ZNTL)에 대한 주식 등급을 재확인하고 목표 주가를 10달러로 유지했습니다.

相关新闻

Zenas BioPharma Prices $300M Concurrent Offerings Of $200M 2.50% Convertible Senior Notes Due 2032 And 5M Shares At $20 To Fund Obexelimab Launch - Zenas BioPharma (NASDAQ:ZBIO)
Benzinga2026-03-27
Zoetis Inc (ZTS) Stock Price Down 3.29% on Mar 18
Gurufocus2026-03-18
H.C. Wainwright reiterates Zentalis stock rating, $10 target By Investing
Au.Investing2026-03-27
HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $44 Price Target - Zenas BioPharma (NASDAQ:ZBIO)
Benzinga2026-03-17
Nektar stock up on trial data for eczema drug (NKTR:NASDAQ)
Seekingalpha2026-02-10

技术分析

信号
布林上轨突破超买MACD看涨站上SMA20
关键指标
77.86RSI (14)
2.66SMA 20
1.75Bollinger Lower
3.57Bollinger Upper
2.66Bollinger Mid
0.16MACD
0.03MACD Signal
0.14MACD Hist
查看股票详情返回暴涨股列表
Zentalis Pharmaceuticals, Inc. +60.1% 暴涨分析 (2026-04-09) | Alpha Lenz